Fundraising Fox

Louis Bock

Investor

Venture Partner at Sante Ventures

Austin, Texas

Writes $100K – $5M checks · typically $1.5M

About

Louis Bock built a biotechnology practice at a historically tech-focused venture firm, backing early winners like Seagen and Horizon, and brings bench-to-business experience from Genentech/Gilead plus ASU tech-transfer board service.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechEnterprise SoftwareHealthtechMedical Devices

Experience

  1. Santé VenturesVenture Partnercurrent2014 — presentAustin, TX
  2. ZogenixBoard Director2006 — 2022San Diego, CA
  3. Skysong Innovations (SI)Board Director2005 — 2021Scottsdale, AZ
  4. PowervisionBoard Director2013 — 2019Belmont, CA
  5. Orexigen TherapeuticsBoard Director2005 — 2018San Diego, CA
  6. Molecular TemplatesBoard Director2013 — 2017Austin, TX
  7. CardiokinetixBoard Director2013 — 2017Menlo Park, CA
  8. Heat BiologicsBoard Director2013 — 2016Durham, NC
  9. New Century Hospice, Inc.Board Director2010 — 2014Dallas, TX
  10. Scale Venture PartnersPartner & Co-Founder1997 — 2014Foster City, CA
  11. Horizon Pharma plcBoard Director2005 — 2012Deerfield, IL
  12. Seattle GeneticsBoard Director1999 — 2002Seattle, WA
  13. Gilead SciencesSales Representative1996 — 1997Foster City, CA
  14. Gilead SciencesDirector, Corporate Development1995 — 1996Foster City, CA
  15. Gilead SciencesSenior Project Manager1992 — 1995Foster City, CA
  16. Gilead SciencesResearch Associate1989 — 1992Foster City, CA
  17. GenentechResearch Associate1987 — 1989South San Francisco, CA

Skills & more

Start-ups3Biotechnology10Venture Capital1Life Sciences3Pharmaceutical Industry1Mergers & Acquisitions1Strategy4Corporate Development4Due Diligence1Entrepreneurship1

From Louis's professional profile.

Investments

Board seats

Horizon TherapeuticsIterion TherapeuticsNew Century HospiceOrexigenPowervisionPrestwick PharmaceuticalsSeaGenSGX PharmaceuticalsSomaxonZogenix

Per the firm's website.

Colleagues at Sante Ventures

Alana Horowitz
Senior Associate at Sante Ventures
Allie Knauer
Venture Fellow at Sante Ventures
Ashley Seehusen
Venture Partner at Sante Ventures
Auriel August
Principal at Sante Ventures
Auriel August, MD
Principal at Sante Ventures
Brendan Boland
Venture Fellow at Sante Ventures
Brooke Jones
Head of Capital Formation at Sante Ventures
Casey Cunningham
Partner and Chief Scientific Officer at Sante Ventures

Network1

Douglas French
Founding Managing Director at Sante Ventures

Investors connected to Louis in public investor directories — a warm-intro map.

Frequently asked questions

Who is Louis Bock?
Louis Bock built a biotechnology practice at a historically tech-focused venture firm, backing early winners like Seagen and Horizon, and brings bench-to-business experience from Genentech/Gilead plus ASU tech-transfer board service.
Where does Louis Bock work?
Louis Bock is Venture Partner at Sante Ventures.
What does Louis Bock invest in?
Louis Bock invests in AI & Machine Learning, Biotech, Enterprise Software, Healthtech, Medical Devices.
What check size does Louis Bock write?
Louis Bock typically writes checks of $100K – $5M.
What boards does Louis Bock sit on?
Louis Bock holds tracked board seats at Horizon Therapeutics, Iterion Therapeutics, New Century Hospice, Orexigen, Powervision, Prestwick Pharmaceuticals, SeaGen, SGX Pharmaceuticals, Somaxon, Zogenix.
Where did Louis Bock go to school?
Louis Bock studied at San Francisco State University (MBA, Finance); California State University, Chico (Bachelor of Science, Biology).

Same school

Also attended San Francisco State University111

Dana ChamorroVice President, Technology at Redpoint VenturesCiara Campbell BowenExecutive Assistant at Sapphire VenturesJulie WalkerInvestor at True VenturesEmily RabbittInvestor at True VenturesStephanie WatkinsOperations at 8VCIndra HusfeldOffice and Finance Coordinator at Sierra Ventures

+ 105 more

Also attended California State University, Chico41

Andrew ReedInvestor at IVP (Institutional Venture Partners)Camilla HellgrenInvestor at EQT VenturesDaniel A. StillPartner and Director of Research at Technology Opportunity Ventures, LlcSarah LuchiniExecutive Assistant at Yamaha Motor VenturesRebecca HarrisOperations / Finance at Standard CryptoMatthew DaughertyDirector at Golden Eagle

+ 35 more

Shared employers

Also worked at Molecular Templates3

Abdul KhanSenior Director, Biologics at Deerfield Management CompanyCaleb WinderManaging Director at MemorialCare Innovation FundCristina GhenoiuPartner at Mubadala Capital

Also worked at Horizon Pharma plc4

Scott KolesarManaging Partner at Caduceus Capital PartnersJacopo LeonardiVenture Advisor at Agent CapitalBarbara ZwolinskaClient Director at Trustmoore LuxembourgJate SamathivathanachaiInvestor at Hyphen Capital

Also worked at Seattle Genetics3

Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Doug WilliamsBiotech Executive & Founding Pillar at Pillar VCDr. Guy PadburySVP, Oncology Clinical Pharmacology at Illinois Ventures

Also worked at Gilead Sciences29

Uri LopatinInvestor at Khosla VenturesJay ParrishVenture Partner at ARCH Venture PartnersPatrick LoerchBio Advisor at Amplify PartnersLaura QuockCBO-in-Residence at Versant VenturesLan WuAnalyst at FusionKate ButlerInvestor at Syncona

+ 23 more